BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8683446)

  • 1. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
    Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
    J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug release mechanism of famotidine time-controlled release pellets].
    Zhang L; Chen DW; Gao ZB
    Yao Xue Xue Bao; 2006 Sep; 41(9):873-7. PubMed ID: 17111836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organic acid-induced sigmoidal release system for oral controlled-release preparations.
    Narisawa S; Nagata M; Danyoshi C; Yoshino H; Murata K; Hirakawa Y; Noda K
    Pharm Res; 1994 Jan; 11(1):111-6. PubMed ID: 8140040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
    Kaur K; Kim K
    Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
    Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
    AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films.
    Wagner K; McGinity J
    J Control Release; 2002 Aug; 82(2-3):385-97. PubMed ID: 12175751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
    Zheng W; Sauer D; McGinity JW
    Eur J Pharm Biopharm; 2005 Jan; 59(1):147-54. PubMed ID: 15567312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
    Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anion-induced water flux as drug release mechanism through cationic Eudragit RS 30D film coatings.
    Wagner KG; Gruetzmann R
    AAPS J; 2005 Oct; 7(3):E668-77. PubMed ID: 16353943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
    Wulff R; Leopold CS
    Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D.
    Bodmeier R; Guo X; Sarabia RE; Skultety PF
    Pharm Res; 1996 Jan; 13(1):52-6. PubMed ID: 8668678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
    Wu C; McGinity JW
    AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying.
    Garekani HA; Moghaddam ZF; Sadeghi F
    Colloids Surf B Biointerfaces; 2013 Aug; 108():374-9. PubMed ID: 23602991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gradation of microcapsule wall porosity by deposition of polymer mixtures (Eudragit RL and Eudragit RS). Phase separation of polymer mixtures and effects of external media and conditions on release.
    Donbrow M; Hoffman A; Benita S
    J Microencapsul; 1995; 12(3):273-85. PubMed ID: 7650592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.